Fetal indusium griseum is a possible biomarker of the regularity of brain midline development in 3T MR imaging: A retrospective observational study

Fuente: Wiley Open Access
Salvato in:
Dettagli Bibliografici
Autori principali: Ivana Pogledic, Mihaela Bobić‐Rasonja, Christian Mitter, Andrija Štajduhar, Ernst Schwartz, Marija Milković‐Periša, Pascal A. Baltzer, Maarten Lequin, Elisabeth Krampl‐Bettelheim, Gregor Kasprian, Miloš Judaš, Daniela Prayer, Natasa Jovanov‐Milosevic
Natura: Artículo Open Access
Pubblicazione: Wiley 2024
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1867013095856013313
author Ivana Pogledic
Mihaela Bobić‐Rasonja
Christian Mitter
Andrija Štajduhar
Ernst Schwartz
Marija Milković‐Periša
Pascal A. Baltzer
Maarten Lequin
Elisabeth Krampl‐Bettelheim
Gregor Kasprian
Miloš Judaš
Daniela Prayer
Natasa Jovanov‐Milosevic
author_facet Ivana Pogledic
Mihaela Bobić‐Rasonja
Christian Mitter
Andrija Štajduhar
Ernst Schwartz
Marija Milković‐Periša
Pascal A. Baltzer
Maarten Lequin
Elisabeth Krampl‐Bettelheim
Gregor Kasprian
Miloš Judaš
Daniela Prayer
Natasa Jovanov‐Milosevic
Ivana Pogledic
Mihaela Bobić‐Rasonja
Christian Mitter
Andrija Štajduhar
Ernst Schwartz
Marija Milković‐Periša
Pascal A. Baltzer
Maarten Lequin
Elisabeth Krampl‐Bettelheim
Gregor Kasprian
Miloš Judaš
Daniela Prayer
Natasa Jovanov‐Milosevic
collection Wiley Open Access
contents Fetal indusium griseum is a possible biomarker of the regularity of brain midline development in 3T MR imaging: A retrospective observational study Ivana Pogledic Mihaela Bobić‐Rasonja Christian Mitter Andrija Štajduhar Ernst Schwartz Marija Milković‐Periša Pascal A. Baltzer Maarten Lequin Elisabeth Krampl‐Bettelheim Gregor Kasprian Miloš Judaš Daniela Prayer Natasa Jovanov‐Milosevic Acta Obstetricia et Gynecologica Scandinavica AbstractIntroductionThis study aimed to assess the visibility of the indusium griseum (IG) in magnetic resonance (MR) scans of the human fetal brain and to evaluate its reliability as an imaging biomarker of the normality of brain midline development.Material and methodsThe retrospective observational study encompassed T2‐w 3T MR images from 90 post‐mortem fetal brains and immunohistochemical sections from 41 fetal brains (16–40 gestational weeks) without cerebral pathology. Three raters independently inspected and evaluated the visibility of IG in post‐mortem and in vivo MR scans. Weighted kappa statistics and regression analysis were used to determine inter‐ and intra‐rater agreement and the type and strength of the association of IG visibility with gestational age.ResultsThe visibility of the IG was the highest between the 25 and 30 gestational week period, with a very good inter‐rater variability (kappa 0.623–0.709) and excellent intra‐rater variability (kappa 0.81–0.93). The immunochemical analysis of the histoarchitecture of IG discloses the expression of highly hydrated extracellular molecules in IG as the substrate of higher signal intensity and best visibility of IG during the mid‐fetal period.ConclusionsThe knowledge of developmental brain histology and fetal age allows us to predict the IG‐visibility in magnetic resonance imaging (MRI) and use it as a biomarker to evaluate the morphogenesis of the brain midline. As a biomarker, IG is significant for post‐mortem pathological examination by MRI. Therefore, in the clinical in vivo imaging examination, IG should be anticipated when an assessment of the brain midline structures is needed in mid‐gestation, including corpus callosum thickness measurements. 10.1111/aogs.14781 http://creativecommons.org/licenses/by-nc-nd/4.0/
doi_str_mv 10.1111/aogs.14781
format Artículo Open Access
id wiley_oa_10_1111_aogs_14781
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Fetal indusium griseum is a possible biomarker of the regularity of brain midline development in 3T MR imaging: A retrospective observational study
Ivana Pogledic
Mihaela Bobić‐Rasonja
Christian Mitter
Andrija Štajduhar
Ernst Schwartz
Marija Milković‐Periša
Pascal A. Baltzer
Maarten Lequin
Elisabeth Krampl‐Bettelheim
Gregor Kasprian
Miloš Judaš
Daniela Prayer
Natasa Jovanov‐Milosevic
Acta Obstetricia et Gynecologica Scandinavica
Fetal indusium griseum is a possible biomarker of the regularity of brain midline development in 3T MR imaging: A retrospective observational study Ivana Pogledic Mihaela Bobić‐Rasonja Christian Mitter Andrija Štajduhar Ernst Schwartz Marija Milković‐Periša Pascal A. Baltzer Maarten Lequin Elisabeth Krampl‐Bettelheim Gregor Kasprian Miloš Judaš Daniela Prayer Natasa Jovanov‐Milosevic Acta Obstetricia et Gynecologica Scandinavica AbstractIntroductionThis study aimed to assess the visibility of the indusium griseum (IG) in magnetic resonance (MR) scans of the human fetal brain and to evaluate its reliability as an imaging biomarker of the normality of brain midline development.Material and methodsThe retrospective observational study encompassed T2‐w 3T MR images from 90 post‐mortem fetal brains and immunohistochemical sections from 41 fetal brains (16–40 gestational weeks) without cerebral pathology. Three raters independently inspected and evaluated the visibility of IG in post‐mortem and in vivo MR scans. Weighted kappa statistics and regression analysis were used to determine inter‐ and intra‐rater agreement and the type and strength of the association of IG visibility with gestational age.ResultsThe visibility of the IG was the highest between the 25 and 30 gestational week period, with a very good inter‐rater variability (kappa 0.623–0.709) and excellent intra‐rater variability (kappa 0.81–0.93). The immunochemical analysis of the histoarchitecture of IG discloses the expression of highly hydrated extracellular molecules in IG as the substrate of higher signal intensity and best visibility of IG during the mid‐fetal period.ConclusionsThe knowledge of developmental brain histology and fetal age allows us to predict the IG‐visibility in magnetic resonance imaging (MRI) and use it as a biomarker to evaluate the morphogenesis of the brain midline. As a biomarker, IG is significant for post‐mortem pathological examination by MRI. Therefore, in the clinical in vivo imaging examination, IG should be anticipated when an assessment of the brain midline structures is needed in mid‐gestation, including corpus callosum thickness measurements. 10.1111/aogs.14781 http://creativecommons.org/licenses/by-nc-nd/4.0/
title Fetal indusium griseum is a possible biomarker of the regularity of brain midline development in 3T MR imaging: A retrospective observational study
topic Acta Obstetricia et Gynecologica Scandinavica
url https://obgyn.onlinelibrary.wiley.com/doi/10.1111/aogs.14781